Please use this identifier to cite or link to this item: http://hdl.handle.net/10609/146723
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMeng, Xueqiong-
dc.contributor.authorCui, Xiaoxi-
dc.contributor.authorShao, Xiaoya-
dc.contributor.authorLiu, Yanqi-
dc.contributor.authorXing, Yihao-
dc.contributor.authorSmith, Victoria-
dc.contributor.authorXiong, Shiqiu-
dc.contributor.authorMacip, Salvador-
dc.contributor.authorChen, Yixiang-
dc.contributor.otherHenan University of Science and Technology-
dc.contributor.otherUniversity of Leicester-
dc.contributor.otherUniversitat Oberta de Catalunya-
dc.date.accessioned2022-08-30T10:16:43Z-
dc.date.available2022-08-30T10:16:43Z-
dc.date.issued2022-04-02-
dc.identifier.issn1936-5233MIAR
-
dc.identifier.urihttp://hdl.handle.net/10609/146723-
dc.description.abstractCervical cancer is one of the most common malignancies in women, with a poor survival rate. Thus, there is a need to define effective combination strategies to improve therapy. In this study, we report that dsRNA poly(I:C) up-regulated the expression of IFNβ and apoptosis-associated genes in cervical cancer cells, activating both intrinsic and extrinsic apoptotic pathways, and eventually inducing cell death. Similarly, proteasome inhibitors also effectively induced cervical cancer cell apoptosis, probably through prevention of p53 degradation, inhibiting NF-κB signal activation and decreasing BCL-2 expression. Importantly, the combination of poly(I:C) with proteasome inhibitors enhanced caspase-8 and caspase-9 activation, and synergistically induced cervical cancer cell apoptosis. Both activated p38 signals and increased ROS levels, and their combination extended these effects. Collectively, we show that the activation of multiple pro-apoptotic pathways by poly(I:C) and proteasome inhibitors underpin a synergistic effect on inducing cervical cancer cell death, suggesting a potential therapeutic combination with clinical relevance.en
dc.format.mimetypeapplication/pdf-
dc.language.isoengca
dc.publisherTranslational Oncologyca
dc.relation.ispartofTranslational Oncology, 2022, 18-
dc.relation.ispartofseries18-
dc.relation.urihttps://doi.org/10.1016/j.tranon.2022.101362-
dc.rightsCC BY-NC-ND 4.0-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0-
dc.subjectcervical canceren
dc.subjectpoly(I.C.)en
dc.subjectproteasome inhibitoren
dc.subjectcombinationen
dc.subjectapoptosisen
dc.subjectcancer cervicales
dc.subjectpoly(I.C.)es
dc.subjectinhibidor del proteasomaes
dc.subjectcombinaciónes
dc.subjectapoptosises
dc.subjectcancer cervicalca
dc.subjectpoly(I.C.)ca
dc.subjectinhibidor del proteasomaca
dc.subjectcombinacióca
dc.subjectapoptosisca
dc.subject.lcshoncologyen
dc.titlepoly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cellsca
dc.typeinfo:eu-repo/semantics/article-
dc.subject.lemaconcologiaca
dc.subject.lcshesoncologíaes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.doihttps://doi.org/10.1016/j.tranon.2022.101362-
dc.type.versioninfo:eu-repo/semantics/publishedVersion-
Appears in Collections:Articles
Articles cientÍfics

Files in This Item:
File Description SizeFormat 
1-s2.0-S1936523322000249-main.pdfpoly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells2,62 MBAdobe PDFThumbnail
View/Open
Share:
Export:
View statistics

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.